Nearly 3 Billion Were at Risk for Malaria in 2009
An estimated 2.85 billion people worldwide were at risk of contracting malaria in 2009, according to a new report published Tuesday in the journal PLos Neglected Tropical Diseases.
bioject
Making Diabetes Less Painful to Deal With
Diabetes patients don’t always engage in the self-care needed to control the disease.
Spherix Shares Rise on Promising Diabetes Drug Data
Shares in Spherix shot up by 77 percent after the biotechnology company announced preliminary Phase III results for its Type 2 diabetes drug candidate.
Zogenix, Astellas Announce Positive Data for Unique Migraine Therapy
Zogenix, a pharmaceutical company specializing in the treatment of chronic pain, and Astellas Pharma have announced positive clinical trial data from two studies of their needle-free migraine treatment system.
Bioject Signs With U.S. Navy for Malaria Vaccine
Bioject Medical Technologies, a developer of needle-free injection systems, has signed a cooperative R&D agreement with the U.S. Navy to use Bioject’s technology in a malaria vaccine the Navy is developing.